Review
Open access
Sep 2026
Advances in Bispecific Antibodies and Antibody–Drug Conjugates for Colorectal Cancer Treatment
BSAbs and bsADCs provide opportunities to improve tumor selectivity, enhance internalization, overcome antigen escape, and expand the population of CRC patients eligible for targeted therapy, as well as discussing the major challenges facing clinical translation.
Maya G. Cappellino, Sean P. Sullivan, Peyton C. High et al.
· Antibodies · 0 citations